Open clinical trials

New England Journal of Medicine

Volumn 357, Issue 17, 2007, Pages 1756-1757

  Drazen, Jeffrey M ^a   Morrissey, Stephen ^a   Curfman, Gregory D ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ROFECOXIB; ROSIGLITAZONE; TELITHROMYCIN;

CLINICAL RESEARCH; DRUG EFFICACY; DRUG MANUFACTURE; DRUG MARKETING; DRUG SAFETY; EDITORIAL; FOOD AND DRUG ADMINISTRATION; MEDICAL LITERATURE; PRIORITY JOURNAL; WORLD HEALTH ORGANIZATION;

EID: 35548935178     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe0706501     Document Type: Editorial

References (4)

1. Office of Inspector General. The Food and Drug Administration's oversight of clinical trials. Washington, DC: Department of Health and Human Services, September 2007. (Accessed October 4, 2007, at http://oig.hhs.gov/oei/reports/ oei-01-06-00160. pdf.)
2. De Angelis C, Drazen JM, Frizelle FA, et al. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. N Engl J Med 2004;351:1250-1.
3. Laine C, Horton R, DeAngelis CD, et al. Clinical trial registration - looking back and moving ahead. N Engl J Med 2007;356:2734-6.
4. World Health Organization. International Clinical Trials Registry Platform (ICTRP). (Accessed October 4, 2007, at http://www.who.int/ictrp.)